Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma × Brentuximab Vedotin × 30 days × Clear all

Sponsor

Conditions

Hodgkin Disease 2 Squamous Cell Carcinoma of Head and Neck 1 Neoplasms 1 Melanoma 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1 Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1 Carcinoma, Non-Small-Cell Lung 1 Ann Arbor Stage IIB Hodgkin Lymphoma 1

Interventions

Cyclophosphamide 6 Vincristine 5 Granulocyte Colony-Stimulating Factor 4 Filgrastim 4 Etoposide 4 Doxorubicin 4 venetoclax 3 prednylidene 3 deltacortene 3 Stem Cell Transplantation 3 Specimen Handling 3 Prednisone 3 Magnetic Resonance Spectroscopy 3 merphos 2 fludarabine phosphate 2 exifone 2 dexamethasone acetate 2 dexamethasone 21-phosphate 2 calaspargase pegol 2 auricularum 2 Whole-Body Irradiation 2 Sirolimus 2 Methylprednisolone 2 Methotrexate 2 Medrol Veriderm 2 Leucovorin 2 Dexamethasone 2 Cytarabine 2 Calcium Dobesilate 2 Azacitidine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡